Abstract

Introduction Bloodstream infections (BSI) among patients with hematological malignancies (HM) could predispose them to higher morbidity and mortality for various underlying conditions. Several microorganisms, either pathogenic or opportunistic normal human flora, could cause severe bacteremia and septicemia. While conventional methods have their own limitations, molecular methods such as next-generation sequencing (NGS) can detect these blood infections with more reliability, specificity, and sensitivity, in addition to information on microbial population landscape. Methodology. Blood samples from HM patients (n = 50) and volunteer blood donor control individuals with no HM (n = 50) were subjected to 16S rRNA gene amplification using standard PCR protocols. A metagenomic library was prepared, and NGS was run on a MiSeq (Illumina) sequencer. Sequence reads were analyzed using MiSeq Reporter, and microbial taxa were aligned using the Green Genes library. Results 82% of the patients showed BSI with Gram-negative bacteria as the most predominant group. E. coli comprised a major chunk of the bacterial population (19.51%), followed by K. pneumoniae (17.07%). The CoNS and Viridans Streptococci groups are 17.07% and 14.63%, respectively. Other major species were S. aureus (9.75%), P. aeruginosa (7.31%), A. baumannii (4.87%), E. cloacae (4.87%), and P. mirabilis (4.87%). 34.14% of the cases among patients showed a Gram-positive infection, while 14.63% showed polymicrobial infections. Conclusion Most of the BSI in patients were characterized by polymicrobial infections, unlike the control samples. Molecular methods like NGS showed robust, fast, and specific identification of infectious agents in BSI in HM, indicating the possibility of its application in routine follow-up of such patients for infections.

Highlights

  • Bloodstream infections (BSI) among patients with hematological malignancies (HM) could predispose them to higher morbidity and mortality for various underlying conditions

  • Hematological malignancies include acute and BioMed Research International chronic myeloid leukemias, acute and chronic lymphocytic leukemias, and various lymphomas and myelomas. With hematological malignancies such as leukemias and lymphomas, bacteremia and bacterial septicemia are a major cause of poor patient outcome [3]

  • The next-generation sequencing (NGS) sequence can give us information on the microbiome—the complete microbial population structure of the study subject unraveling a plethora of information required for successful treatment, including the antibiotic resistance genes that the organism carries

Read more

Summary

Introduction

Bloodstream infections (BSI) among patients with hematological malignancies (HM) could predispose them to higher morbidity and mortality for various underlying conditions. While conventional methods have their own limitations, molecular methods such as next-generation sequencing (NGS) can detect these blood infections with more reliability, specificity, and sensitivity, in addition to information on microbial population landscape. With hematological malignancies such as leukemias and lymphomas, bacteremia and bacterial septicemia are a major cause of poor patient outcome [3]. Patients with hematological malignancies have higher risks of contracting bloodstream infections (BSI) owing to immunological dysfunction as a result of chemo and radiotherapy. Next-generation sequencing (NGS) has been very popular for its robustness, speed, accuracy, and large number of samples it can handle at a time This technology can identify viable, dead, viable but not culturable (VBNC) bacteria, fungi, and viruses in multiple heterogeneous sample pools. The NGS sequence can give us information on the microbiome—the complete microbial population structure of the study subject unraveling a plethora of information required for successful treatment, including the antibiotic resistance genes that the organism carries

Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call